Kankana Bardhan

2.9k total citations · 2 hit papers
23 papers, 2.3k citations indexed

About

Kankana Bardhan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kankana Bardhan has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Kankana Bardhan's work include Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Epigenetics and DNA Methylation (4 papers). Kankana Bardhan is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Epigenetics and DNA Methylation (4 papers). Kankana Bardhan collaborates with scholars based in United States, Australia and Georgia. Kankana Bardhan's co-authors include Vassiliki A. Boussiotis, Theodora Anagnostou, Kebin Liu, Nikolaos Patsoukis, Pankaj Seth, Gordon J. Freeman, Duygu Sari, Pranam Chatterjee, Lauren N. Bell and Lequn Li and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kankana Bardhan

23 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation

2015 908 citations Nikolaos Patsoukis, Kankana Bardhan et al. Nature Communications profile →
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

2016 445 citations Kankana Bardhan, Theodora Anagnostou et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Kankana Bardhan

Since Specialization

Citations

This map shows the geographic impact of Kankana Bardhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kankana Bardhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kankana Bardhan more than expected).

Fields of papers citing papers by Kankana Bardhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kankana Bardhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kankana Bardhan. The network helps show where Kankana Bardhan may publish in the future.

Co-authorship network of co-authors of Kankana Bardhan

This figure shows the co-authorship network connecting the top 25 collaborators of Kankana Bardhan. A scholar is included among the top collaborators of Kankana Bardhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kankana Bardhan. Kankana Bardhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors. 2021 ·Journal of Clinical Oncology ·Michal Sarfaty, Christopher A. Desjardins, Paul A. Giardina, Kankana Bardhan, (unknown), (unknown), (unknown), Margaret K. Callahan, Michael A. Postow, Chung‐Han Lee, Ritesh R. Kotecha, (unknown), (unknown), Ashley Marie Regazzi, Matthew R. Henn, Matthew D. Hellmann, Gopa Iyer, Christopher B. Ford, Jonathan U. Peled	2
2	Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells 2019 ·Scientific Reports ·Kankana Bardhan, Halil‐Ibrahim Aksoylar, (unknown), Laura Strauss, Jessica D. Weaver, Bethany Delcuze, Alain Charest, Nikolaos Patsoukis, Vassiliki A. Boussiotis	25
3	Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity 2019 ·Cell Reports ·Lynnette Marcar, Kankana Bardhan, Liliana Gheorghiu, (unknown), (unknown), Qi Liu, (unknown), Zofia Piotrowska, Lecia V. Sequist, Kerstin Borgmann, Jeffrey Settleman, Jeffrey A. Engelman, Aaron N. Hata, Henning Willers	49
4	The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression 2017 ·Science Signaling ·Nikolaos Patsoukis, Kankana Bardhan, Jessica D. Weaver, Duygu Sari, (unknown), Lequn Li, Laura Strauss, Esther M. Lafuente, Vassiliki A. Boussiotis	21
5	The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation breakdown → 2016 ·Frontiers in Immunology ·Kankana Bardhan, Theodora Anagnostou, Vassiliki A. Boussiotis	445
6	Interaction of Both SH2 Domains of SHP-2 with a PD-1 Homodimer Is Required for PD-1-Mediated Inhibition of T Cell Responses 2016 ·Blood ·Nikolaos Patsoukis, Anders H. Berg, Kankana Bardhan, Jessica D. Weaver, Kathleen M. Mahoney, Gordon J. Freeman, Vassiliki A. Boussiotis	4
7	NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression 2016 ·Oncotarget ·(unknown), Kankana Bardhan, (unknown), Amy V. Paschall, Chunwan Lu, Roni J. Bollag, (unknown), Jian‐Yue Jin, Feng‐Ming Kong, Jennifer L. Waller, Raphael E. Pollock, Kebin Liu	13
8	Clinical significance of T cell metabolic reprogramming in cancer 2016 ·Clinical and Translational Medicine ·Christoph Herbel, Nikolaos Patsoukis, Kankana Bardhan, Pankaj Seth, Jessica D. Weaver, Vassiliki A. Boussiotis	72
9	The role of metabolic reprogramming in T cell fate and function. 2016 ·PubMed ·Nikolaos Patsoukis, Kankana Bardhan, Jessica D. Weaver, Christoph Herbel, Pankaj Seth, Lequn Li, Vassiliki A. Boussiotis	36
10	Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2 2016 ·Oncotarget ·Anthos Christofides, Theodoros Karantanos, Kankana Bardhan, Vassiliki A. Boussiotis	46
11	IFNγ Induces DNA Methylation–Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer 2015 ·Cancer Immunology Research ·Kankana Bardhan, Amy V. Paschall, Dafeng Yang, (unknown), (unknown), Yangzom D. Bhutia, Pamela M. Martin, Muthusamy Thangaraju, Darren D. Browning, Vadivel Ganapathy, (unknown), Keni Gu, Jeffrey R. Lee, Kebin Liu	40
12	PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation breakdown → 2015 ·Nature Communications ·Nikolaos Patsoukis, Kankana Bardhan, Pranam Chatterjee, Duygu Sari, Bianling Liu, Lauren N. Bell, Edward D. Karoly, Gordon J. Freeman, Victoria Petkova, Pankaj Seth, Lequn Li, Vassiliki A. Boussiotis	908
13	IFN Regulatory Factor 8 Represses GM-CSF Expression in T Cells To Affect Myeloid Cell Lineage Differentiation 2015 ·The Journal of Immunology ·Amy V. Paschall, Ruihua Zhang, Chen‐Feng Qi, Kankana Bardhan, Peng Liang, Geming Lu, Jianjun Yang, Miriam Mérad, Tracy L. McGaha, Gang Zhou, Andrew L. Mellor, Scott I. Abrams, Herbert C. Morse, Keiko Ozato, Huabao Xiong, Kebin Liu	45
14	Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer 2013 ·Journal of Biological Chemistry ·Xiao Hu, Kankana Bardhan, Amy V. Paschall, Dafeng Yang, Jennifer L. Waller, (unknown), Asha Nayak-Kapoor, Thomas A. Samuel, Scott I. Abrams, Kebin Liu	59
15	Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation 2013 ·Carcinogenesis ·Xiao Hu, Mary Ann Zimmerman, Kankana Bardhan, Dafeng Yang, Jennifer L. Waller, Georgia Liles, Jeffrey R. Lee, Raphael E. Pollock, Dina Lev, Carl F. Ware, Ellen A. Garber, Véronique Bailly, Jeffrey L. Browning, Kebin Liu	26
16	GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology 2013 ·Molecular and Cellular Biology ·(unknown), Lei Huang, Jillian Bradley, Kebin Liu, Kankana Bardhan, David Ron, Andrew L. Mellor, David H. Munn, Tracy L. McGaha	66
17	Epigenetics and Colorectal Cancer Pathogenesis 2013 ·Cancers ·Kankana Bardhan, Kebin Liu	189
18	NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression 2012 ·Journal of Biological Chemistry ·Feiyan Liu, Kankana Bardhan, Dafeng Yang, Muthusamy Thangaraju, Vadivel Ganapathy, Jennifer L. Waller, Georgia Liles, Jeffrey R. Lee, Kebin Liu	117
19	Abstract 3140: Constitutive and regulated expression of GPR109A by DNA methylation and IFN-γ in human colon carcinoma cells 2012 ·Cancer Research ·Kankana Bardhan, Vadivel Ganapathy, Kebin Liu	1
20	Decitabine and Vorinostat Cooperate To Sensitize Colon Carcinoma Cells to Fas Ligand-Induced Apoptosis In Vitro and Tumor Suppression In Vivo 2012 ·The Journal of Immunology ·Dafeng Yang, Christina Torres‐Rouff, Kankana Bardhan, Mary Ann Zimmerman, Tracy L. McGaha, Kebin Liu	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact